Monocyte CD40 expression in head and neck squamous cell carcinoma (HNSCC)

Human Immunology

Volumn 74, Issue 1, 2013, Pages 1-5

  Sathawane, Devendra ^a   Kharat, Ravindran S ^b   Halder, Subhadra ^a   Roy, Somenath ^c   Swami, Ravi ^b   Patel, Ritim ^b   Saha, Bhaskar ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b Bharati Vidyapeeth's Medical College   (India)

^c VIDYASAGAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCYTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD40; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CD40 LIGAND; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MONOCYTES; NEOPLASM STAGING; SIGNAL TRANSDUCTION; SOLUBILITY; T-LYMPHOCYTES;

EID: 84870923481     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.09.004     Document Type: Article

References (11)

1. Shah J.P. Patterns of cervical lymph node metastasis from Squamous carcinomas of the upper aerodigestive tract. Am J Surg 1990, 160:405-409.
2. Haddad R.I., Shin D.M. Recent advances in head and neck cancer. N Engl J Med 2008, 359:1143.
3. De Costa A.M., Young M.R. Immunotherapy for head and neck cancer: advances and deficiencies. Anticancer Drugs 2011, 22:674-681.
4. Murugaiyan G., Agrawal R., Mishra G.C., Mitra D., Saha B. Functional dichotomy in CD40 reciprocally regulates effector T cell functions. J Immunol 2006, 177:6642-6649.
5. Murugaiyan G., Agrawal R., Mishra G.C., Mitra D., Saha B. Differential CD40/CD40L expression results in counteracting anti-tumor immune responses. J Immunol 2007, 178:2047-2055.
6. Murugaiyan G., Martin S., Saha B. Levels of CD40 expression on dendritic cells dictate tumour growth or regression. Clin Exp Immunol 2007, 149:194-202.
7. Venuprasad K., Chattopadhyay S., Saha B. CD28 signaling in neutrophil induces T cell chemotactic factor(s) modulating T cell response. Hum Immunol 2003, 46:38-43.
8. Posner M.R., Cavacini L.A., Upton M.P., Tillman K.C., Gornstein E.R., Norris C.M. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines. Clin Cancer Res 1999, 5:2261-2270.
9. Martin S., Agrawal R., Murugaiyan G., Saha B. CD40 expression levels modulate regulatory T cells in Leishmania donovani infection. J Immunol 2010, 185:551-559.
10. Khan S., Alonso L., Roduit C., Bandyopadhyay S., Singh S., Saha S., et al. Differential peptide binding to CD40 evokes counteractive responses. Human Immunol 2012, 73:27-31.
11. Beatty G.L., Chiorean E.G., Fishman M.P., Saboury B., Teitelbaum U.R., Sun W., et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011, 331:1612-1616.